GENE ONLINE|News &
Opinion
Blog

LATEST
Vertex Is Looking to Become Singapore’s First SPAC
2022-01-10
GlaxoSmithKline’s Shingles Vaccine Available in Singapore
2022-01-10
FDA Approves Drug for Schizophrenia in Pediatric Patients
2022-01-10
Amgen Taps Generate to Discover Multi-Target Protein Drugs in $1.9+ Billion Deal
2022-01-07
Scientists Work On an Oral Vaccine Booster for COVID-19
2022-01-07
Novartis Teams Up with Alnylam to Explore Targeted Liver Therapies
2022-01-07
GeneOnline’s Top 10 Hong Kong Biotech IPOs of 2021
2022-01-07
Celltrion’s New Antibody Is Effective against the Omicron Variant
2022-01-06
Korro Bio Raises $116 Million for RNA Editing Program
2022-01-06
Gannex Pharma Announces New Dual Targeting Drug for NASH
2022-01-05
Roche Looks for Peptide-Like Small Molecules with Prism BioLab, joining Merck, Eisai and Boehringer Ingelheim
2022-01-05
GeneOnline’s Pick: Notable Novel FDA Approved Drugs in 2021
2022-01-05
Scientists to Study the Effect of Microgravity on Human Brain Cells in Space
2022-01-04
Applied Therapeutics’ Galactosemia Program Stumbles Again after FDA Requests for More Data
2022-01-04
RNAi Player Sirnaomics Squeezes in $50 Million IPO in Hong Kong
2022-01-03
1 102 103 104 105 106 218
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top